Behind the Buzzword: Market Access

market access: man looking at prescription medication bottles in a medicine cabinet

Payer pressure is rising, and regulatory structures are growing more complex around the globe. So it’s no surprise that life sciences companies are trying to formalize the way they address these challenges. Developing comprehensive market access strategies—and creating dedicated internal teams to develop and execute them—has emerged as a powerful approach.

Read the latest piece in our Behind the Buzzword series to learn more.

What is market access?

Market access is the process through which companies ensure that the patients who would benefit from their assets get rapid and maintained access to them. It draws together experts in health economics, pricing, regulations, patient engagement, communications, and more.

What’s challenging about it?

Many life sciences companies are trying to make market access an integral part of their organizations. But the urgent emphasis on these roles is producing a scarcity of skilled talent for this critical function. Companies are also struggling to create efficient, streamlined processes for managing a complicated workload.

How can on-demand talent help?

A growing number of market access specialists now work independently, and can step in to help on projects that range from value proposition development to project management and operations execution. Thanks to their high expertise and low overhead, they’ve enabled market access groups to work smarter, faster, and more flexibly throughout the product development cycle.

Business Talent Group’s independent access consultants have helped clients with projects that range from IDN value development to oncology access support. They represent a wide range of therapeutic area and geographic specialties, and can offer expert advice, augment your team’s capabilities, or step in as seasoned project managers.

Need help with market access?

Start a project »
Learn more about our capabilities »

Case Study: Innovations in Market Access

Learn how Business Talent Group's independent experts helped a global life science company create a framework for evaluating pharmaceutical affordability models.

READ THE CASE STUDY

 

About the Author

Leah Hoffmann

Leah Hoffmann is BTG's Content Strategist. A former journalist, Leah worked for Forbes.com and The Economist before joining BTG. She is passionate about clear thinking, sharp writing, and strong points of view.

More Content by Leah Hoffmann
Previous Article
Behind the Buzzword: Digital Health
Behind the Buzzword: Digital Health

What is digital health, and what opportunities does it offer today's health and life science companies and ...

Next Article
Strategy at Scale: Internal Consulting Group Best Practices
Strategy at Scale: Internal Consulting Group Best Practices

Daniel Lee, who created Pfizer's Consulting and Execution Group, or PCE, shares best practices for building...

Find the perfect life science consultant.

Start a Project